Florida cardiology ASC partners with Avertix Medical

Cardiology ASC the Heart & Rhythm Institute of Trinity (Fla.) has partnered with Avertix Medical, a company focused on improving long-term management for coronary disease patients, to make Avertix’s Guardian System available to the ASC’s patients and physicians. 

Advertisement

The Guardian System is the only FDA-approved implantable heart attack detection and warning system, according to an Aug. 16 press release. 

The device will be available to Heart & Rhythm’s 10 cardiologists who work across seven cardiology practices and seven hospitals in the area. 

Cardiologists Luis Annoni-Suau, MD, and Carlos Bayron, MD, performed the first two Guardian implant procedures at Heart & Rhythm. 

The implantable device continuously captures cardiac signals from inside the heart to provide alerts to patients and healthcare professionals 24 hours a day. It can detect acute coronary syndrome events including heart attacks, even silent and atypical symptomatic heart attacks, in real-time.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Cardiology

Advertisement

Comments are closed.